PROTHEA TECHNOLOGIES LIMITED

Active Edinburgh

Research and experimental development on biotechnology

10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PROTHEA TECHNOLOGIES LIMITED

Research and experimental development on biotechnology

Founded 14 Jun 2021 Active Edinburgh, Scotland 10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Feb 2026 Next due 28 Feb 2026 2 months overdue
Confirmation Submitted 13 Jun 2025 Next due 27 Jun 2026 2 months remaining
Net assets £3M £3M 2024 year on year
Total assets £3M £3M 2024 year on year
Total Liabilities £289K £158K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

City Point 3rd Floor, 65 Haymarket Terrace Edinburgh EH12 5HD Scotland

Website

www.example.com

Full company profile for PROTHEA TECHNOLOGIES LIMITED (SC701542), an active life sciences and medical technology company based in Edinburgh, Scotland. Incorporated 14 Jun 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£2.63M

Increased by £2.57M (+4286%)

Net Assets

£3.07M

Increased by £3.44M (+919%)

Total Liabilities

£289.27k

Decreased by £158.17k (-35%)

Turnover

N/A

Employees

10

Increased by 9 (+900%)

Debt Ratio

9%

Decreased by 603 (-99%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2024Series A
Investor 2Apr 2024Series A
Investor 3Apr 2024Series A

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,041,086 Shares £5.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Nov 2025771,426€5.40m€7
22 Nov 2023100,000£100£0.001
3 Nov 2023140,000£140£0.001
21 Aug 202329,660£29.66£0.001

Officers

Officers

3 active
Status
Charles Stanwood CarignanDirectorAmericanUnited States6128 Mar 2024Active
Thomas Franz Josef RaueiserDirectorGermanGermany5128 Mar 2024Active
Thorntons Law LlpCorporate-secretaryUnited KingdomUnknown14 Jun 2021Active

Shareholders

Shareholders (16)

Merieux Equity Partners Sas, As Director On Behalf Of Omx Europe Venture Fund
16.2%
314,285
Earlybird Health Ii Fund Gmbh & Co. Kg
16.2%
314,285

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased
Ceased

Dominic Crispin Adam Simon

Ceased 27 Oct 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Feb 2026AccountsAnnual accounts made up to 2025-02-28
9 Dec 2025MiscellaneousReplacement filing of SH01 - 04/12/25 Statement of Capital gbp 2714.281
8 Dec 2025ResolutionResolutions
5 Dec 2025CapitalAllotment of shares (GBP 2,714.281) on 2025-12-04
13 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-13 with updates
27 Feb 2026 Accounts

Annual accounts made up to 2025-02-28

9 Dec 2025 Miscellaneous

Replacement filing of SH01 - 04/12/25 Statement of Capital gbp 2714.281

8 Dec 2025 Resolution

Resolutions

5 Dec 2025 Capital

Allotment of shares (GBP 2,714.281) on 2025-12-04

13 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-13 with updates

Recent Activity

Latest Activity

Annual accounts made up to 2025-02-28

1 months ago on 27 Feb 2026

Replacement filing of SH01 - 04/12/25 Statement of Capital gbp 2714.281

4 months ago on 9 Dec 2025

Resolutions

4 months ago on 8 Dec 2025

Allotment of shares (GBP 2,714.281) on 2025-12-04

4 months ago on 5 Dec 2025

Confirmation statement made on 2025-06-13 with updates

10 months ago on 13 Jun 2025